Oviva, a London and Zurich based digital health company has raised $12m in Series A funding. Eight Roads Ventures invested alongside sister fund, F-Prime Capital Partners, Albion Capital, Partech Ventures and Walking Ventures.
Oviva’s technology and nutritional treatment programmes were designed and tested by specialist clinicians and healthcare experts, with the ambition to dramatically increase patients’ access to tailored and effective treatments for diet-related conditions such as type 2 diabetes, obesity, and food allergies. It uses virtual clinics and high frequency follow up to increase system capacity and improve clinical outcomes, lowering the cost of care. Its app allows patients to message their dietitians directly and self-record their food intake, weight, and activity, giving patients personalised support without the hassle of having to attend regular group sessions or clinical appointments.
Oviva was founded in 2014 and has already helped over 20’000 patients across the UK, Switzerland and Germany to improve their health, and works alongside professional bodies for dietitians including the British Dietetic Association and the German Society for Nutrition. Oviva will use this capital to expand its operations across Europe and further develop its product to better serve the millions of patients outside the current community of dietetics services.
Oviva has recently been selected as one of five digital providers for the NHS England Digital Diabetes Prevention Programme. The Oviva Diabetes Prevention Programme has the potential to significantly reduce the number of new diagnoses of type 2 diabetes each year in England and save millions of pounds for the NHS, helping patients to avoid complications of diabetes such as eye, kidney and heart disease.